Miyawaki S, Sakamaki H, Ohtake S, et al; A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia. Cancer2005; 104: 2726-34.
Goldstone AH, Burnett AK, Wheatley K, et al Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Counsil AML 11 trial. Blood2001; 98; 1302-11
Wahlin A, Markevarn B, Golovleva I, et al Prognostic significance of risk group strarification in elderly patients with acute myeloid leukaemia. Br J Haemato12001; 115: 25-33
Menzin J, Lang K, Earle CC, et al: The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med.2002; 162:1597-603
Grimwade D, Walker H, Oliver F, et al: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood1998; 92: 2322-33